Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings

IQVIA Holdings (IQV) reported $3.96 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 2.3%. EPS of $3.12 for the same period compares to $2.84 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $3.92 billion, representing a surprise of +0.89%. The company delivered an EPS surprise of +0.65%, with the consensus EPS estimate being $3.10.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how IQVIA performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Backlog: $31.1 billion compared to the $31.9 billion average estimate based on two analysts. Revenues- Technology & Analytics Solutions: $1.66 billion versus the six-analyst average estimate of $1.63 billion. The reported number represents a year-over-year change of +8.3%. Revenues- Research & Development Solution: $2.12 billion versus $2.11 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -1.3% change. Revenues- Contract Sales & Medical Solutions: $177 million compared to the $178.17 million average estimate based on six analysts. The reported number represents a change of -4.8% year over year. View all Key Company Metrics for IQVIA here>>>Shares of IQVIA have returned +0.6% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IQVIA Holdings Inc. (IQV): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks